130 related articles for article (PubMed ID: 28733244)
1. Response surface optimization, Ex vivo and In vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone.
Abdelrahman FE; Elsayed I; Gad MK; Elshafeey AH; Mohamed MI
Int J Pharm; 2017 Sep; 530(1-2):1-11. PubMed ID: 28733244
[TBL] [Abstract][Full Text] [Related]
2. Investigating the cubosomal ability for transnasal brain targeting: In vitro optimization, ex vivo permeation and in vivo biodistribution.
Abdelrahman FE; Elsayed I; Gad MK; Badr A; Mohamed MI
Int J Pharm; 2015 Jul; 490(1-2):281-91. PubMed ID: 26026251
[TBL] [Abstract][Full Text] [Related]
3. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies.
Fahmy AM; El-Setouhy DA; Ibrahim AB; Habib BA; Tayel SA; Bayoumi NA
Drug Deliv; 2018 Nov; 25(1):12-22. PubMed ID: 29219628
[TBL] [Abstract][Full Text] [Related]
4. Development of risperidone liposomes for brain targeting through intranasal route.
Narayan R; Singh M; Ranjan O; Nayak Y; Garg S; Shavi GV; Nayak UY
Life Sci; 2016 Oct; 163():38-45. PubMed ID: 27593571
[TBL] [Abstract][Full Text] [Related]
5. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
Qureshi M; Aqil M; Imam SS; Ahad A; Sultana Y
Curr Drug Deliv; 2019; 16(2):123-135. PubMed ID: 30317997
[TBL] [Abstract][Full Text] [Related]
6. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.
Patel S; Chavhan S; Soni H; Babbar AK; Mathur R; Mishra AK; Sawant K
J Drug Target; 2011 Jul; 19(6):468-74. PubMed ID: 20958095
[TBL] [Abstract][Full Text] [Related]
7. Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies.
Nour SA; Abdelmalak NS; Naguib MJ; Rashed HM; Ibrahim AB
Drug Deliv; 2016 Nov; 23(9):3681-3695. PubMed ID: 27648847
[TBL] [Abstract][Full Text] [Related]
8. Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies.
Elsenosy FM; Abdelbary GA; Elshafeey AH; Elsayed I; Fares AR
Int J Nanomedicine; 2020; 15():9517-9537. PubMed ID: 33324051
[TBL] [Abstract][Full Text] [Related]
9. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
[TBL] [Abstract][Full Text] [Related]
10. Nanosized Cubosomal Thermogelling Dispersion Loaded with Saquinavir Mesylate to Improve Its Bioavailability: Preparation, Optimization, in vitro and in vivo Evaluation.
Hosny KM
Int J Nanomedicine; 2020; 15():5113-5129. PubMed ID: 32764940
[TBL] [Abstract][Full Text] [Related]
11. Self-Assembling Lecithin-Based Mixed Polymeric Micelles for Nose to Brain Delivery of Clozapine: In-vivo Assessment of Drug Efficacy via Radiobiological Evaluation.
M Elsharkawy F; M Amin M; A Shamsel-Din H; Ibrahim W; Ibrahim AB; Sayed S
Int J Nanomedicine; 2023; 18():1577-1595. PubMed ID: 37007986
[TBL] [Abstract][Full Text] [Related]
12. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
Shah B; Khunt D; Misra M; Padh H
Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of Transdermal Delivery of Haloperidol via Spanlastic Dispersions: Entrapment Efficiency vs. Particle Size.
Fahmy AM; El-Setouhy DA; Habib BA; Tayel SA
AAPS PharmSciTech; 2019 Jan; 20(3):95. PubMed ID: 30694404
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
16. Formulation and characterization of lamotrigine nasal insert targeted brain for enhanced epilepsy treatment.
Abdelmonem R; El-Enin HAA; Abdelkader G; Abdel-Hakeem M
Drug Deliv; 2023 Dec; 30(1):2163321. PubMed ID: 36579655
[TBL] [Abstract][Full Text] [Related]
17. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
18. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.
Kumar M; Misra A; Babbar AK; Mishra AK; Mishra P; Pathak K
Int J Pharm; 2008 Jun; 358(1-2):285-91. PubMed ID: 18455333
[TBL] [Abstract][Full Text] [Related]
19. Optimization of topical curcumin spanlastics for melanoma treatment.
Ismail S; Garhy D; Ibrahim HK
Pharm Dev Technol; 2023 Jun; 28(5):425-439. PubMed ID: 37078715
[TBL] [Abstract][Full Text] [Related]
20. Novel instantly-dispersible nanocarrier powder system (IDNPs) for intranasal delivery of dapoxetine hydrochloride: in-vitro optimization, ex-vivo permeation studies, and in-vivo evaluation.
Fouad SA; Shamma RN; Basalious EB; El-Nabarawi MM; Tayel SA
Drug Dev Ind Pharm; 2018 Sep; 44(9):1443-1450. PubMed ID: 29614890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
